Sherwood
Wednesday Jan.13, 2021

💻 Zoom's $1.75B stock sale

"_Welcome to ZWork"_
"_Welcome to ZWork"_

Hey Snackers,

Yesterday, the House passed a resolution to encourage Vice President Pence to invoke the 25th Amendment to remove Trump — after Pence said he wouldn't. The House impeachment vote will happen today.

While major stocks barely budged, the Russell 2000 index — which tracks 2K smaller publicly traded US companies — hit a record high. Investors are betting on more stimulus and an economic recovery, which could turn the tide for small(er) biz.

Sell

Zoom looks to raise $1.75B with a new share sale — but why?

If it's a verb... It needs no intro. Flashback to December 2019: WFH days are a rare perk, masks are for spa days, and Zoom stock is trading at $65. Flashforward to October 2020: WFH is a meme-ified norm, masks are for all days, and Zoom stock is trading at $560. Oh, and its quarterly profit has increased 3,300% from 2019.

  • But Zoom has been kind of muted lately... Now that Covid-19 vaccines are being administered, shares have fallen to $357. And Zoom wants to cash in before it's too late.
  • Zoom plans to sell 5M+ new shares to raise $1.75B in fresh cash. Since more shares are being introduced, Zoom stockholders will own less of the overall company — that dilutes the value of exisiting shares.

Conference FOMO... Zoom hasn't cashed in on its soaring share price yet. When you buy a company's stock, the company isn't getting your dollars. The $$$ goes to the random other investor you bought the stock from (just like when you sell, it goes to you). But these new share sales are kind of rare for public companies (though Tesla has announced two this year), because no one wants dilution. So why is Zoom doing this now?

Zoom could be gearing up to invest... in a "return-to-work" hedge. Zoom doesn't have a cash problem: on October 31, it had $1.9B in cash, according to its latest earnings. So this share sale isn't a needy cash grab. Zoom is the ultimate WFH stock - that's both its greatest strength and its greatest vulnerability. Now it could be gearing up to invest in (or even acquire) a "return-to-normalcy" hedge. We're thinking it should launch a remote co-working space called ZWork.

Cool

Walmart tests an outdoor "smart cooler" for anytime grocery delivery

If a mailbox had a baby with a WiFi-connected Igloo cooler... you'd get HomeValet. This "smart cooler" chills on your doorstep, waiting for the grocery delivery so you don't have to. Walmart's partnering with the startup behind HomeValet for a grocery delivery pilot in Bentonville, Arkansas (aka: Walmart HQ).

  • Secure & contact-less: Only you and the delivery guy/gal can unlock the box.
  • Temp-controlled: Three temperature zones — refrigerated, frozen, and room temp (for the Nutella).
  • Phone-controlled: Set your HomeValet to 0° F straight from the app.
  • Disinfecting: Bacteria-crushing UV lights sanitize your eggplant.

Walmart isn't famous for its e-nnovation... but it is famous for groceries. Walmart = largest grocer in the US. This partnership with HomeValet could give it an innovative edge against techy Instacart and Amazon. In fact, Walmart customers will be the first to gain access to HomeValet boxes (they haven't even dropped yet).

Prime goes wide, Walmart+ goes deep... into grocery. Makes sense, since groceries account for over half of Walmart's sales. ICYMI: Walmart+ is the $98/year Amazon Prime rival. Prime offers everything from free shipping, to video, to Music, and yes... grocery delivery. But Walmart+ has one major selling point: free unlimited grocery delivery. HomeValet could level up Walmart's grocery by expanding perks.

What else we’re Snackin’

  • Swabbed: The US will require all international passengers to show a negative Covid-19 test before boarding US-bound flights.
  • Future: GM shares hit a record high after the OG carmaker unveiled an insane-looking electric van and potential plans to delve into flying cars.
  • Cruise: Carnival expects a net loss of $2.2B for its fourth quarter, but says it ended the year with $9.5B in cash.
  • Shack: Shake Shack's quarterly sales finally grew after several quarters of declines — but same-store sales in Manhattan plunged 49%.
  • Vax: The Trump admin is reportedly issuing guidelines to expand Covid vaccine eligibility to anyone 65 and over.

Wednesday

Authors of this Snacks own shares of: Walmart

ID: 1477357

Get Your News

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Latest Stories

Go Deeper with Market Depth

Nasdaq TotalView powers the need-to-know data serious investors rely on.

Scuba Diving in the Wild Blue Yonder in French Polynesia
339% raise

Call it the Undertaker bump: Endeavor and TKO Group CEO Ari Emanuel got a hefty raise after helming the $9.3B merger between UFC and WWE.

According to The Hollywood Reporter, Emanuel pulled in $84M last year, a 339% raise from 2022. Emanuel made $1,184 to every $1 Endeavor’s median employee made.

Still, it doesn’t compare to Emanuel’s $308M Endeavor pay package from 2021 — before he was this guy’s boss — which was mostly thanks to a restricted stock grant.

Disney has its worst day in a year

The House of Mouse got some rough reviews Tuesday after it reported a small Q1 loss of $20 million, while emphasizing that it reduced red ink in its costly streaming unit from $659 million in Q1 2023 to $18 million. Still, a loss is a loss. Shortly after the start of trading, Disney was having its worst day in a year.

Your inbox is ready

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

power

US spies get their own gen AI “divorced” from the internet

Spies are just like us: they want generative AI to do their work for them. And now, thanks to Microsoft, which developed a gen-AI model for US intelligence agencies, they can. Uniquely, the model doesn’t run on the internet, where it could potentially leak sensitive information.

US spies can now use this GPT4-based model to analyze large amounts of classified data and presumably sound like a self-assured high-school report in their communications.

Of course it’s possible they're also inheriting many of gen AI’s less intelligent problems, like hallucinations and factual inaccuracies.

Of course it’s possible they're also inheriting many of gen AI’s less intelligent problems, like hallucinations and factual inaccuracies.

tech

Apple betting its chips on AI for servers

We finally have a look at one of Apple’s long-awaited AI plays: the development of a chip to run AI software in data centers, codenamed Project ACDC or Apple Chips in Data Center. Whether this is enough to bring the iPhone maker up to speed with its Big Tech rivals in the AI space remains to be seen, but its stock is up on the news.

tech

Gamers are still buying the Switch console in their millions, as its successor appears on the horizon

Sales of the 7-year-old Switch console are holding up better than Nintendo expected, as the Japanese company reported shifting 15.7 million units of the display-diverse device in the 12 months to March 2024, beating its own predictions.

More importantly, however, Nintendo finally gave something of update on the Switch’s successor, which is now set to be announced in the coming fiscal year.

Although Switch sales have stayed surprisingly strong... they’re still falling, highlighting how difficult the business of game hardware can be. You need a new hit every 7-10 years, as sales typically peak 3-5 years after release before dropping sharply. That slowdown is beginning to flow through to Nintendo’s bottom line, with the company forecasting a ~40% annual drop in profit this year, per CNBC. The Switch sequel, whatever it looks like, has some big shoes to fill.

Nintendo console sales

More importantly, however, Nintendo finally gave something of update on the Switch’s successor, which is now set to be announced in the coming fiscal year.

Although Switch sales have stayed surprisingly strong... they’re still falling, highlighting how difficult the business of game hardware can be. You need a new hit every 7-10 years, as sales typically peak 3-5 years after release before dropping sharply. That slowdown is beginning to flow through to Nintendo’s bottom line, with the company forecasting a ~40% annual drop in profit this year, per CNBC. The Switch sequel, whatever it looks like, has some big shoes to fill.

Nintendo console sales
tech

Apple's big “ad” business is mostly cashing their $20B check from Google

In what was mostly a disappointing earnings report with declining iPhones sales, Apple was quick to point out that its services segment notched record revenue. Advertising, the company keeps saying, is helping drive those services numbers.

But Business Insider’s Peter Kafka reports Apple’s ad business isn’t what normal people think of when they think of ads.

While Apple does have a more traditional ads business, there’s a huge “third-party licensing arrangement" it tucks into its ad revenue line. In 2022, Google paid Apple more than $20 billion to be the default search on iPhones and other Apple devices, according to antitrust documents.

Traditional ads make up about 6% of Apple's annual services revenue, while the Google deal brings in more than 20%.

While Apple does have a more traditional ads business, there’s a huge “third-party licensing arrangement" it tucks into its ad revenue line. In 2022, Google paid Apple more than $20 billion to be the default search on iPhones and other Apple devices, according to antitrust documents.

Traditional ads make up about 6% of Apple's annual services revenue, while the Google deal brings in more than 20%.

crypto

Robinhood Crypto joins other major exchanges as target of SEC Wells notice

Earlier today Robinhood Crypto said that it'd received a so-called Wells notice from the Securities and Exchange Commission on May 4, suggesting the regulator may be prepping some sort of enforcement action against the retail trading giant. (Robinhood Markets Inc. is the parent company of Sherwood Media.)

The SEC has argued that many cryptocurrencies are securities, and should be regulated as such. Dan Gallagher, Robinhood’s chief legal, compliance, and corporate affairs officer, said in a statement that the company believes the assets listed on its crypto platform are not securities.

A Wells notice does not always precede an enforcement action, which Robinhood said in an 8-K could include an injunction, a cease-and desist order, or civil penalties (among other outcomes).

The market mostly brushed off the news, with Robinhood Markets, Inc. shares largely recovering after a brief morning slide.

The SEC has argued that many cryptocurrencies are securities, and should be regulated as such. Dan Gallagher, Robinhood’s chief legal, compliance, and corporate affairs officer, said in a statement that the company believes the assets listed on its crypto platform are not securities.

A Wells notice does not always precede an enforcement action, which Robinhood said in an 8-K could include an injunction, a cease-and desist order, or civil penalties (among other outcomes).

The market mostly brushed off the news, with Robinhood Markets, Inc. shares largely recovering after a brief morning slide.

tech

The Apple Watch gets FDA approval for use in clinical trials

The Apple Watch has bigger applications than your daily step count.

The FDA just approved the watch's heart monitoring tech for use in clinical trials, making it the first digital health gadget to be greenlit through its Medical Device Development Tools program.

Stats from the watch's atrial fibrillation (AFib) tracking tool can now be used in medical device clinical trial as a secondary source of data. It's a vote of confidence for the Apple Watch, which has been at the heart of lawsuits from several medtech companies.

Stats from the watch's atrial fibrillation (AFib) tracking tool can now be used in medical device clinical trial as a secondary source of data. It's a vote of confidence for the Apple Watch, which has been at the heart of lawsuits from several medtech companies.